SRS Capital Advisors »

Protara Therapeutic shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Protara Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Protara Therapeutic held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protara Therapeutic by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $209 48 4.35

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Protara Therapeutic

Henderson Group
BlackRock
Velan Capital Investment Management
Blackstone Group
Vanguard Group
Acorn Capital Advisors
Catalio Capital Management
Integral Health Asset Management
UBS Group
5AM Venture Management
Geode Capital Management
Millennium Management
Baker Bros. Advisors
Citadel Advisors
Driehaus Capital Management

View all funds holding Protara Therapeutic